Stammdaten
Sionna Therapeutics, Inc. ist ein biopharmazeutisches Unternehmen. Das Unternehmen stellt Therapiekonzepte für Mukoviszidose-Patienten bereit, indem es Arzneimittel entwickelt, die die Funktion des Cystic-Fibrosis-Transmembrane-Conductance-Regulators normalisieren. KI
Unternehmen & Branche
| Name | Sionna Therapeutics, Inc. |
|---|---|
| Ticker | SION |
| CIK | 0002036042 |
| Börse | Nasdaq |
| Sektor | Gesundheit |
| Industrie | Biotechnologie (Forschung) |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 829401108 |
|---|---|
| ISIN | US8294011080 |
| Typ | Common Stock |
| Marktkapitalisierung | 2,03 Mrd. USD |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 21 HICKORY DRIVE, SUITE 500, 02451 WALTHAM, MA |
| Telefon | 617-819-2020 |
| EIN (IRS) | 00-0000000 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Emerging growth company |
Bewertung
| KBV (P/B) | 6,61 |
|---|---|
| FCF-Rendite | -3,3 % |
Qualität & Bilanz
| ROIC | -23,9 % |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2024. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|
| Bewertung | ||||
| KBV (P/B) | – | 6,00 | 7,04 | |
| FCF-Rendite | – | -3,6 % | -3,6 % | |
| Qualität & Bilanz | ||||
| ROIC | – | -23,9 % | -28,9 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
SION
Sionna Therapeutics, Inc.
Effektiv
Schwach
Handelsvolumen
Mittel
Insider
0,0
Keine Insider-Käufe
Institutionell
27,9
28 neu, 38 erhöht, -41105K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 41.15 | +10.3 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 39.48 | +14.9 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 44.28 | EMA50: 42.27 | |
| MACD-Histogramm | Bärisch | 10 % | -0.145 | Bearisch | |
| RSI(14) | Neutral | 10 % | 54.4 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 37.3 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 29.5 | +DI: 19.7 / −DI: 9.4 | |
| Z-Score(60) | Neutral | 5 % | 1.11 | In Range | |
| 52W-Position | Bullisch | 5 % | 87.7 % | Hoch 49.41 / Tief 16.76 | |
| Bollinger(20,2σ) | Neutral | 5 % | 60.7 % | Upper 47.96 / Mid 44.68 / Lower 41.40 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.0818 | R²=0.15 / annualisiert +49.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | Thompson Peter A. | Director | Open Market Sale | -85.918 | 44,86 | -3.854.281,48 | -348,7% | |
| 2026-07-07 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -85.918 | 44,86 | -3.854.281,48 | -348,7% | |
| 2026-07-06 | Fitzpatrick Jennifer | Officer, Chief Legal Officer | Open Market Sale | -10.250 | 43,60 | -446.862,08 | -40,4% | |
| 2026-06-30 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -115.844 | 45,50 | -5.270.902,00 | -476,9% | |
| 2026-06-30 | Thompson Peter A. | Director | Open Market Sale | -115.844 | 45,50 | -5.270.902,00 | -476,9% | |
| 2026-05-27 | Thompson Peter A. | Director | Open Market Sale | -101 | 44,49 | -4.493,49 | -0,4% | |
| 2026-05-27 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -101 | 44,49 | -4.493,49 | -0,4% | |
| 2026-05-11 | Thompson Peter A. | Director | Open Market Sale | -184.639 | 46,22 | -8.534.014,58 | -772,1% | |
| 2026-05-11 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -184.639 | 46,22 | -8.534.014,58 | -772,1% | |
| 2026-05-08 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -59.767 | 44,58 | -2.664.412,86 | -241,1% | |
| 2026-05-08 | Thompson Peter A. | Director | Open Market Sale | -59.767 | 44,58 | -2.664.412,86 | -241,1% | |
| 2026-05-07 | Thompson Peter A. | Director | Open Market Sale | -48.546 | 44,61 | -2.165.637,06 | -195,9% | |
| 2026-05-07 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -48.546 | 44,61 | -2.165.637,06 | -195,9% | |
| 2026-04-18 | Thompson Peter A. | Director | Open Market Sale | -2.948 | 44,52 | -131.244,96 | -11,9% | |
| 2026-04-18 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -2.948 | 44,52 | -131.244,96 | -11,9% | |
| 2026-04-17 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -52.397 | 44,68 | -2.341.097,96 | -211,8% | |
| 2026-04-17 | Thompson Peter A. | Director | Open Market Sale | -52.397 | 44,68 | -2.341.097,96 | -211,8% | |
| 2026-04-16 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -226.906 | 45,34 | -10.287.918,04 | -930,8% | |
| 2026-04-16 | Thompson Peter A. | Director | Open Market Sale | -226.906 | 45,34 | -10.287.918,04 | -930,8% | |
| 2026-04-15 | Thompson Peter A. | Director | Open Market Sale | -235.863 | 44,64 | -10.528.924,32 | -952,6% | |
| 2026-04-15 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -235.863 | 44,64 | -10.528.924,32 | -952,6% | |
| 2026-04-14 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -47.814 | 44,51 | -2.128.201,14 | -192,5% | |
| 2026-04-14 | Thompson Peter A. | Director | Open Market Sale | -47.814 | 44,51 | -2.128.201,14 | -192,5% | |
| 2026-03-05 | Fitzpatrick Jennifer | Officer, Chief Legal Officer | Open Market Sale | -10.250 | 33,86 | -347.018,88 | -31,4% | |
| 2026-02-03 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -29.063 | 44,58 | -1.295.628,54 | -117,2% | |
| 2026-02-03 | Thompson Peter A. | Director | Open Market Sale | -29.063 | 44,58 | -1.295.628,54 | -117,2% | |
| 2026-02-02 | Thompson Peter A. | Director | Open Market Sale | -1.890 | 44,57 | -84.237,30 | -7,6% | |
| 2026-02-02 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -1.890 | 44,57 | -84.237,30 | -7,6% | |
| 2026-01-22 | TPG GP A, LLC | 10% Owner | Open Market Sale | -250.000 | 40,00 | -10.000.000,00 | -904,7% | |
| 2025-12-24 | Thompson Peter A. | Director | Open Market Sale | -33.356 | 44,55 | -1.486.009,80 | -134,4% | |
| 2025-12-24 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -33.356 | 44,55 | -1.486.009,80 | -134,4% | |
| 2025-12-19 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -875 | 44,49 | -38.928,75 | -3,5% | |
| 2025-12-19 | Thompson Peter A. | Director | Open Market Sale | -875 | 44,49 | -38.928,75 | -3,5% | |
| 2025-12-18 | Thompson Peter A. | Director | Open Market Sale | -100 | 44,49 | -4.449,00 | -0,4% | |
| 2025-12-18 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -100 | 44,49 | -4.449,00 | -0,4% | |
| 2025-12-17 | Thompson Peter A. | Director | Open Market Sale | -900 | 44,50 | -40.050,00 | -3,6% | |
| 2025-12-17 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -900 | 44,50 | -40.050,00 | -3,6% | |
| 2025-12-05 | Fitzpatrick Jennifer | Officer, Chief Legal Officer | Open Market Sale | -10.250 | 40,52 | -415.330,00 | -37,6% | |
| 2025-11-26 | Thompson Peter A. | Director | Open Market Sale | -1.600 | 44,49 | -71.184,00 | -6,4% | |
| 2025-11-26 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -1.600 | 44,49 | -71.184,00 | -6,4% | |
| 2025-11-25 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -11.890 | 44,60 | -530.294,00 | -48,0% | |
| 2025-11-25 | Thompson Peter A. | Director | Open Market Sale | -11.890 | 44,60 | -530.294,00 | -48,0% | |
| 2025-11-24 | Thompson Peter A. | Director | Open Market Sale | -94.583 | 44,54 | -4.212.726,82 | -381,1% | |
| 2025-11-24 | ORBIMED ADVISORS LLC | Director | Open Market Sale | -94.583 | 44,54 | -4.212.726,82 | -381,1% | |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -6.440 | 39,50 | -254.380,00 | -23,0% | |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -9.924 | 39,50 | -391.998,00 | -35,5% | |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -7.609 | 39,50 | -300.555,50 | -27,2% | |
| 2025-11-21 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -1.210 | 39,50 | -47.795,00 | -4,3% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -150 | 39,89 | -5.983,50 | -0,5% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -1.235 | 39,89 | -49.264,15 | -4,5% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -947 | 39,89 | -37.775,83 | -3,4% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -801 | 39,89 | -31.951,89 | -2,9% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -788 | 40,50 | -31.914,00 | -2,9% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -604 | 40,50 | -24.462,00 | -2,2% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -512 | 40,50 | -20.736,00 | -1,9% | |
| 2025-11-20 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -96 | 40,50 | -3.888,00 | -0,4% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -8 | 40,61 | -324,88 | 0,0% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -18.684 | 40,01 | -747.546,84 | -67,6% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -14.325 | 40,01 | -573.143,25 | -51,9% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -12.126 | 40,01 | -485.161,26 | -43,9% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2.276 | 40,01 | -91.062,76 | -8,2% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -12 | 40,61 | -487,32 | 0,0% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -9 | 40,61 | -365,49 | 0,0% | |
| 2025-11-19 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2 | 40,61 | -81,22 | 0,0% | |
| 2025-11-18 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -332 | 39,57 | -13.137,24 | -1,2% | |
| 2025-11-18 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2.728 | 39,57 | -107.946,96 | -9,8% | |
| 2025-11-18 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2.092 | 39,57 | -82.780,44 | -7,5% | |
| 2025-11-18 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -1.770 | 39,57 | -70.038,90 | -6,3% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -280 | 42,10 | -11.788,00 | -1,1% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -53 | 42,10 | -2.231,30 | -0,2% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -331 | 42,10 | -13.935,10 | -1,3% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -433 | 42,10 | -18.229,30 | -1,6% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -1.701 | 41,05 | -69.826,05 | -6,3% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -2.182 | 40,20 | -87.716,40 | -7,9% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -9.063 | 41,05 | -372.036,15 | -33,7% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -10.707 | 41,05 | -439.522,35 | -39,8% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -11.626 | 40,20 | -467.365,20 | -42,3% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -13.734 | 40,20 | -552.106,80 | -50,0% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -13.964 | 41,05 | -573.222,20 | -51,9% | |
| 2025-11-17 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -17.913 | 40,20 | -720.102,60 | -65,1% | |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -17.118 | 39,58 | -677.530,44 | -61,3% | |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -10.476 | 39,58 | -414.640,08 | -37,5% | |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -3.624 | 39,58 | -143.437,92 | -13,0% | |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -31.392 | 39,58 | -1.242.495,36 | -112,4% | |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -122.271 | 39,50 | -4.829.704,50 | -437,0% | |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -66.672 | 39,50 | -2.633.544,00 | -238,3% | |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -14.116 | 39,50 | -557.582,00 | -50,4% | |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Sale | -107.941 | 39,50 | -4.263.669,50 | -385,7% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -5.763 | 34,91 | -201.186,33 | -18,2% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -5.316 | 35,69 | -189.728,04 | -17,2% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -4.688 | 32,69 | -153.250,72 | -13,9% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -4.187 | 33,87 | -141.813,69 | -12,8% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -1.210 | 34,91 | -42.241,10 | -3,8% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -17 | 36,42 | -619,14 | -0,1% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -83 | 36,42 | -3.022,86 | -0,3% | |
| 2025-10-21 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -33.532 | 37,31 | -1.251.078,92 | -113,2% | |
| 2025-10-21 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -30.049 | 35,63 | -1.070.645,87 | -96,9% | |
| 2025-10-21 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -22.895 | 36,60 | -837.957,00 | -75,8% | |
| 2025-10-21 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -13.324 | 34,44 | -458.878,56 | -41,5% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -25.327 | 35,69 | -903.920,63 | -81,8% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -22.339 | 32,69 | -730.261,91 | -66,1% | |
| 2025-10-21 | Booth Bruce | Director | Open Market Sale | -19.948 | 33,87 | -675.638,76 | -61,1% | |
| 2025-10-20 | Booth Bruce | Director | Open Market Sale | -5.412 | 32,33 | -174.969,96 | -15,8% | |
| 2025-10-20 | Booth Bruce | Director | Open Market Sale | -25.788 | 32,33 | -833.726,04 | -75,4% | |
| 2025-10-20 | Booth Bruce | Director | Open Market Sale | -20.485 | 31,79 | -651.218,15 | -58,9% | |
| 2025-10-20 | Booth Bruce | Director | Open Market Sale | -4.300 | 31,79 | -136.697,00 | -12,4% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -21.451 | 32,71 | -701.662,21 | -63,5% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -28.821 | 32,10 | -925.154,10 | -83,7% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -6.049 | 32,10 | -194.172,90 | -17,6% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -4.503 | 32,71 | -147.293,13 | -13,3% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -248 | 33,47 | -8.300,56 | -0,8% | |
| 2025-10-17 | Booth Bruce | Director | Open Market Sale | -52 | 33,47 | -1.740,44 | -0,2% | |
| 2025-10-16 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -200 | 34,00 | -6.800,00 | -0,6% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -73.296 | 32,84 | -2.407.040,64 | -217,8% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -45.117 | 31,69 | -1.429.757,73 | -129,4% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -15.384 | 32,84 | -505.210,56 | -45,7% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -12.888 | 33,38 | -430.201,44 | -38,9% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -9.470 | 31,69 | -300.104,30 | -27,2% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -8.596 | 30,15 | -259.169,40 | -23,4% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -2.705 | 33,38 | -90.292,90 | -8,2% | |
| 2025-10-16 | Booth Bruce | Director | Open Market Sale | -1.804 | 30,15 | -54.390,60 | -4,9% | |
| 2025-10-16 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -10.225 | 31,46 | -321.690,77 | -29,1% | |
| 2025-10-15 | Booth Bruce | Director | Open Market Sale | -13.795 | 30,37 | -418.954,15 | -37,9% | |
| 2025-10-15 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -14.775 | 31,11 | -459.662,07 | -41,6% | |
| 2025-10-15 | Booth Bruce | Director | Open Market Sale | -65.726 | 30,37 | -1.996.098,62 | -180,6% | |
| 2025-10-15 | Booth Bruce | Director | Open Market Sale | -30.032 | 31,12 | -934.595,84 | -84,6% | |
| 2025-10-15 | Booth Bruce | Director | Open Market Sale | -6.303 | 31,12 | -196.149,36 | -17,7% | |
| 2025-10-14 | Booth Bruce | Director | Open Market Sale | -501 | 29,95 | -15.004,95 | -1,4% | |
| 2025-10-14 | Booth Bruce | Director | Open Market Sale | -105 | 29,95 | -3.144,75 | -0,3% | |
| 2025-10-13 | Booth Bruce | Director | Open Market Sale | -4.082 | 31,03 | -126.664,46 | -11,5% | |
| 2025-10-13 | Booth Bruce | Director | Open Market Sale | -44.048 | 30,32 | -1.335.535,36 | -120,8% | |
| 2025-10-13 | Booth Bruce | Director | Open Market Sale | -9.245 | 30,32 | -280.308,40 | -25,4% | |
| 2025-10-13 | Booth Bruce | Director | Open Market Sale | -857 | 31,03 | -26.592,71 | -2,4% | |
| 2025-10-10 | Booth Bruce | Director | Open Market Sale | -3.511 | 29,98 | -105.259,78 | -9,5% | |
| 2025-10-10 | Booth Bruce | Director | Open Market Sale | -16.727 | 29,98 | -501.475,46 | -45,4% | |
| 2025-10-06 | Booth Bruce | Director | Open Market Sale | -9.753 | 29,95 | -292.102,35 | -26,4% | |
| 2025-10-06 | Booth Bruce | Director | Open Market Sale | -2.047 | 29,95 | -61.307,65 | -5,5% | |
| 2025-10-03 | Booth Bruce | Director | Open Market Sale | -6.548 | 30,00 | -196.440,00 | -17,8% | |
| 2025-10-03 | Booth Bruce | Director | Open Market Sale | -31.198 | 30,00 | -935.940,00 | -84,7% | |
| 2025-10-01 | Booth Bruce | Director | Open Market Sale | -35 | 29,95 | -1.048,25 | -0,1% | |
| 2025-10-01 | Booth Bruce | Director | Open Market Sale | -165 | 29,95 | -4.941,75 | -0,4% | |
| 2025-09-30 | Booth Bruce | Director | Open Market Sale | -2.149 | 30,06 | -64.598,94 | -5,8% | |
| 2025-09-30 | Booth Bruce | Director | Open Market Sale | -10.239 | 30,06 | -307.784,34 | -27,8% | |
| 2025-09-29 | Booth Bruce | Director | Open Market Sale | -54.637 | 30,09 | -1.644.027,33 | -148,7% | |
| 2025-09-29 | Booth Bruce | Director | Open Market Sale | -11.468 | 30,09 | -345.072,12 | -31,2% | |
| 2025-09-29 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -7.793 | 29,70 | -231.451,32 | -20,9% | |
| 2025-09-26 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -17.207 | 28,85 | -496.346,24 | -44,9% | |
| 2025-09-04 | Fitzpatrick Jennifer | Officer, Chief Legal Officer | Open Market Sale | -10.250 | 23,12 | -236.980,00 | -21,4% | |
| 2025-09-02 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -8.836 | 25,08 | -221.606,88 | -20,0% | |
| 2025-08-29 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -748 | 25,18 | -18.834,64 | -1,7% | |
| 2025-08-28 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -16.098 | 25,97 | -418.065,06 | -37,8% | |
| 2025-08-27 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -3.618 | 25,10 | -90.811,80 | -8,2% | |
| 2025-08-27 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -7.426 | 25,01 | -185.713,86 | -16,8% | |
| 2025-08-26 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -3.700 | 25,13 | -92.981,00 | -8,4% | |
| 2025-08-26 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -17.574 | 24,96 | -438.647,04 | -39,7% | |
| 2025-08-20 | Cloonan Michael | Director, Officer, President & CEO | Open Market Sale | -25.000 | 22,75 | -568.750,00 | -51,5% | |
| 2025-08-20 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -17.500 | 22,69 | -397.075,00 | -35,9% | |
| 2025-08-19 | Ridloff Elena | Officer, CFO & Head of Corp. Dev. | Open Market Sale | -34.500 | 21,08 | -727.260,00 | -65,8% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.905.045 | 0 | 9.905.045 | 397.093.254 | Neu | +100,0% | |
| TPG GP A, LLC | 6.494.962 | 0 | 6.494.962 | 260.383.027 | Neu | +100,0% | |
| ORBIMED ADVISORS LLC | 3.530.702 | 0 | 3.530.702 | 141.545.843 | Neu | +100,0% | |
| VIKING GLOBAL INVESTORS LP | 3.195.181 | 0 | 3.195.181 | 128.094.806 | Neu | +100,0% | |
| Atlas Venture Life Science Advisors, LLC | 2.995.602 | 0 | 2.995.602 | 120.093.684 | Neu | +100,0% | |
| Enavate Sciences GP, LLC | 2.478.030 | 0 | 2.478.030 | 99.344.223 | Neu | +100,0% | |
| JENNISON ASSOCIATES LLC | 1.451.220 | 0 | 1.451.220 | 58.179.411 | Neu | +100,0% | |
| BlackRock, Inc. | 1.295.867 | 0 | 1.295.867 | 51.951.309 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 1.166.931 | 0 | 1.166.931 | 46.782.264 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.029.497 | 0 | 1.029.497 | 41.272.535 | Neu | +100,0% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 970.590 | 0 | 970.590 | 38.910.953 | Neu | +100,0% | |
| STATE STREET CORP | 756.227 | 0 | 756.227 | 30.317.140 | Neu | +100,0% | |
| PERCEPTIVE ADVISORS LLC | 658.439 | 0 | 658.439 | 26.396.820 | Neu | +100,0% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 645.530 | 0 | 645.530 | 25.875.888 | Neu | +100,0% | |
| Aberdeen Group plc | 564.175 | 0 | 564.175 | 22.617.776 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 400.000 | 0 | 400.000 | 16.036.000 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 389.872 | 0 | 389.872 | 15.633.527 | Neu | +100,0% | |
| Siren, L.L.C. | 300.000 | 0 | 300.000 | 12.027.000 | Neu | +100,0% | |
| Sio Capital Management, LLC | 294.340 | 0 | 294.340 | 11.800.091 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 293.500 | 0 | 293.500 | 11.766.415 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 263.174 | 0 | 263.174 | 10.550.646 | Neu | +100,0% | |
| Ensign Peak Advisors, Inc | 255.636 | 0 | 255.636 | 10.248.447 | Neu | +100,0% | |
| Candriam S.C.A. | 236.813 | 0 | 236.813 | 9.493.833 | Neu | +100,0% | |
| Kalehua Capital Management LLC | 197.072 | 0 | 197.072 | 7.900.616 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 175.483 | 0 | 175.483 | 7.035.113 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 150.000 | 0 | 150.000 | 6.013.500 | Neu | +100,0% | |
| UBS Group AG | 147.641 | 0 | 147.641 | 5.918.928 | Neu | +100,0% | |
| SUPERSTRING CAPITAL MANAGEMENT LP | 141.024 | 0 | 141.024 | 5.653.652 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 140.641 | 0 | 140.641 | 5.638.298 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 136.549 | 0 | 136.549 | 5.474.249 | Neu | +100,0% | |
| Alyeska Investment Group, L.P. | 136.222 | 0 | 136.222 | 5.461.140 | Neu | +100,0% | |
| GordonMD Global Investments LP | 136.000 | 0 | 136.000 | 5.452.240 | Neu | +100,0% | |
| MORGAN STANLEY | 133.023 | 0 | 133.023 | 5.332.893 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 120.253 | 0 | 120.253 | 4.820.943 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 116.776 | 0 | 116.776 | 4.681.551 | Neu | +100,0% | |
| Rock Springs Capital Management LP | 99.429 | 0 | 99.429 | 3.986.109 | Neu | +100,0% | |
| Rhenman & Partners Asset Management AB | 87.500 | 0 | 87.500 | 3.507.875 | Neu | +100,0% | |
| TD ASSET MANAGEMENT INC | 82.996 | 0 | 82.996 | 3.327.310 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 81.974 | 0 | 81.974 | 3.286.338 | Neu | +100,0% | |
| FMR LLC | 81.395 | 0 | 81.395 | 3.263.126 | Neu | +100,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 76.633 | 0 | 76.633 | 3.072.217 | Neu | +100,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 64.458 | 0 | 64.458 | 2.584.121 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 50.870 | 0 | 50.870 | 2.039.378 | Neu | +100,0% | |
| Integral Health Asset Management, LLC | 50.000 | 0 | 50.000 | 2.004.500 | Neu | +100,0% | |
| SEVEN GRAND MANAGERS, LLC | 50.000 | 0 | 50.000 | 2.004.500 | Neu | +100,0% | |
| Ishara Investments LP | 49.200 | 0 | 49.200 | 1.972.428 | Neu | +100,0% | |
| Russell Investments Group, Ltd. | 48.419 | 0 | 48.419 | 1.941.133 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 46.079 | 0 | 46.079 | 1.847.306 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 42.242 | 0 | 42.242 | 1.693.482 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 40.570 | 0 | 40.570 | 1.626.451 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| China Universal Asset Management Co., Ltd. | 7.186 | 7.920 | -9,3% | 316.112 | 35,71 | 100 % | 4 Q |
| Police & Firemen's Retirement System of New Jersey | 5.438 | 4.232 | +28,5% | 239.218 | 27,02 | 100 % | 5 Q |
| AlphaCentric Advisors LLC | 4.863 | 4.818 | +0,9% | 213.923 | 24,17 | 0 % | 3 Q |
| Mirae Asset Global Investments Co., Ltd. | 2.019 | 2.328 | -13,3% | 88.816 | 10,03 | 100 % | 3 Q |
| GAMMA Investing LLC | 244 | 238 | +2,5% | 10.734 | 1,21 | 100 % | 4 Q |
| Farther Finance Advisors, LLC | 196 | 196 | 0,0% | 8.622 | 0,97 | 0 % | 3 Q |
| Sterling Capital Management LLC | 65 | 105 | -38,1% | 2.859 | 0,32 | 0 % | 5 Q |
| Bare Financial Services, Inc | 37 | 0 | +100,0% | 1.628 | 0,18 | 100 % | 1 Q |
| Hughes Financial Services, LLC | 25 | 26 | -3,8% | 1.100 | 0,12 | 100 % | 5 Q |
| EverSource Wealth Advisors, LLC | 20 | 23 | -13,0% | 880 | 0,10 | 100 % | 4 Q |
| Fortitude Family Office, LLC | 15 | 15 | 0,0% | 660 | 0,07 | 100 % | 2 Q |
| SJS Investment Consulting Inc. | 9 | 0 | +100,0% | 396 | 0,04 | 0 % | 1 Q |
| CONTRAVISORY INVESTMENT MANAGEMENT, INC. | 6 | 0 | +100,0% | 264 | 0,03 | 100 % | 1 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 13 | 0,0 | 1 |
| 31.03.2026 | ✓ | 119 | 47,3 | 1.860 |
| 31.12.2025 | ✓ | 98 | 43,9 | 1.771 |
| 30.09.2025 | ✓ | 77 | 44,8 | 1.300 |
| 30.06.2025 | ✓ | 64 | 43,5 | 738 |
| 31.03.2025 | ✓ | 47 | 43,3 | 443 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| Sio Capital Management, LLC | 294.340 | 11.800.091 |
| Candriam S.C.A. | 236.813 | 9.493.833 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 150.000 | 6.013.500 |
| Point72 Asset Management, L.P. | 136.549 | 5.474.249 |
| GordonMD Global Investments LP | 136.000 | 5.452.240 |
| Rhenman & Partners Asset Management AB | 87.500 | 3.507.875 |
| Integral Health Asset Management, LLC | 50.000 | 2.004.500 |
| Ishara Investments LP | 49.200 | 1.972.428 |
| Qube Research & Technologies Ltd | 42.242 | 1.693.482 |
| STEMPOINT CAPITAL LP | 36.540 | 1.464.889 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 1.451.220 | 335.942 | +30.1 % | 58.179.411 |
| GOLDMAN SACHS GROUP INC | 263.174 | 226.905 | +625.6 % | 10.550.646 |
| Ensign Peak Advisors, Inc | 255.636 | 175.774 | +220.1 % | 10.248.447 |
| MORGAN STANLEY | 133.023 | 83.147 | +166.7 % | 5.332.893 |
| FMR LLC | 81.395 | 81.011 | +21096.6 % | 3.263.126 |
| CITADEL ADVISORS LLC | 1.166.931 | 79.606 | +7.3 % | 46.782.264 |
| STATE STREET CORP | 756.227 | 62.832 | +9.1 % | 30.317.140 |
| MILLENNIUM MANAGEMENT LLC | 140.641 | 60.095 | +74.6 % | 5.638.298 |
| UBS Group AG | 147.641 | 58.464 | +65.6 % | 5.918.928 |
| BNP PARIBAS FINANCIAL MARKETS | 40.570 | 38.306 | +1692.0 % | 1.626.451 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 658.439 | -520.659 | -44.2 % | 26.396.820 |
| Aberdeen Group plc | 564.175 | -275.785 | -32.8 % | 22.617.776 |
| TPG GP A, LLC | 6.494.962 | -250.000 | -3.7 % | 260.383.027 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 756.376 | -74.997 | -9.0 % | 30.324 |
| Longaeva Partners L.P. | 12.693 | -67.036 | -84.1 % | 508.862 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 141.024 | -39.569 | -21.9 % | 5.653.652 |
| ORBIMED ADVISORS LLC | 3.530.702 | -30.953 | -0.9 % | 141.545.843 |
| TD ASSET MANAGEMENT INC | 82.996 | -30.356 | -26.8 % | 3.327.310 |
| BARCLAYS PLC | 18.385 | -29.787 | -61.8 % | 737.056 |
| AMERIPRISE FINANCIAL INC | 81.974 | -19.669 | -19.4 % | 3.286.338 |
Zusätzlich aktuell von 78 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck | Δ-Balken |
|---|---|---|---|---|---|---|---|
| 15.05.2026 | Viking Global Opportunities Illiquid Investments Sub-Master LP (+2) | Passiv (13G/A) | 4,50 % | 2.039.801 | +0,20 pp | – | |
| 15.05.2026 | Viking Global Opportunities Drawdown Portfolio GP LLC (+2) | Passiv (13G/A) | 2,60 % | 1.155.380 | +0,20 pp | – | |
| 15.05.2026 | Viking Global Opportunities Parent GP LLC (+3) | Passiv (13G/A) | 7,10 % | 3.195.181 | +0,40 pp | – | |
| 12.05.2026 | Qatar Investment Authority (+1) | Passiv (13G/A) | 4,50 % | 2.020.258 | -0,50 pp | – | |
| 21.04.2026 | OrbiMed Capital GP VIII LLC (+1) | Aktivist (13D/A) | 6,60 % | 2.967.722 | -1,80 pp | The Reporting Persons from time to time intend to review their investment in the Issuer … | |
| 07.11.2025 | RA Capital Nexus Fund III, L.P. | Aktivist (13D/A) | 5,00 % | 2.240.708 | -0,30 pp | – | |
| 07.11.2025 | RA Capital Management, L.P. (+2) | Aktivist (13D/A) | 22,60 % | 10.071.712 | -1,10 pp | – | |
| 07.11.2025 | RA Capital Healthcare Fund, L.P. | Aktivist (13D/A) | 15,50 % | 6.905.625 | -0,20 pp | – | |
| 31.10.2025 | JPMORGAN CHASE & CO. | Passiv (13G/A) | 4,40 % | 1.980.626 | -0,60 pp | – | |
| 20.10.2025 | Atlas Venture Associates XI, L.P. (+2) | Aktivist (13D/A) | 5,40 % | 2.382.495 | -1,10 pp | – | |
| 20.10.2025 | Atlas Venture Associates Opportunity II, LLC (+2) | Aktivist (13D/A) | 1,60 % | 701.985 | -0,20 pp | – | |
| 30.07.2025 | JPMORGAN CHASE & CO. | Passiv (13G) | 5,00 % | 2.221.188 | Neu | – | |
| 16.06.2025 | Qatar Investment Authority (+1) | Passiv (13G) | 5,00 % | 2.209.775 | Neu | – | |
| 18.02.2025 | James G. Coulter (+2) | Aktivist (13D) | 15,20 % | 6.684.962 | Neu | The information set forth in or incorporated by reference in Items 2, 3, 5 and 6 of this… | |
| 18.02.2025 | Atlas Venture Associates Opportunity II, LLC (+2) | Aktivist (13D) | 1,80 % | 807.727 | Neu | The Reporting Persons acquired the Common Stock for investment purposes. Except as set f… | |
| 18.02.2025 | Atlas Venture Associates XI, L.P. (+2) | Aktivist (13D) | 6,50 % | 2.886.293 | Neu | The Reporting Persons acquired the Common Stock for investment purposes. Except as set f… | |
| 18.02.2025 | RA Capital Healthcare Fund, L.P. | Aktivist (13D) | 15,70 % | 6.923.365 | Neu | The Reporting Persons acquired the Common Stock reported herein for investment purposes … | |
| 18.02.2025 | RA Capital Management, L.P. (+2) | Aktivist (13D) | 23,70 % | 10.445.322 | Neu | The Reporting Persons acquired the Common Stock reported herein for investment purposes … | |
| 18.02.2025 | RA Capital Nexus Fund III, L.P. | Aktivist (13D) | 5,30 % | 2.324.498 | Neu | The Reporting Persons acquired the Common Stock reported herein for investment purposes … | |
| 18.02.2025 | Enavate Sciences GP, LLC (+1) | Aktivist (13D) | 5,60 % | 2.478.030 | Neu | The Reporting Persons purchased the aforementioned securities for investment purposes wi… | |
| 14.02.2025 | Viking Global Opportunities Illiquid Investments Sub-Master LP (+2) | Passiv (13G) | 4,30 % | 1.894.346 | Neu | – | |
| 14.02.2025 | Viking Global Opportunities Parent GP LLC (+4) | Passiv (13G) | 6,70 % | 2.952.754 | Neu | – | |
| 14.02.2025 | Viking Global Opportunities Drawdown Portfolio GP LLC (+2) | Passiv (13G) | 2,40 % | 1.058.408 | Neu | – | |
| 13.02.2025 | OrbiMed Capital GP VIII LLC (+1) | Aktivist (13D) | 8,40 % | 3.704.959 | Neu | This Statement on Schedule 13D relates to the acquisition of Shares by the Reporting Per… |
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | -26.779.000 $ | -0,60 $ | 305.039.000 $ | 288.208.000 $ |
| 2025-12-31 | 10-K | – | -75.268.000 $ | -1,88 $ | 325.953.000 $ | 306.833.000 $ |
| 2025-09-30 | 10-Q | – | -20.278.000 $ | -0,46 $ | 339.270.000 $ | 321.668.000 $ |
| 2025-06-30 | 10-Q | – | -18.068.000 $ | -410,00 $ | 352.048.000 $ | 336.429.000 $ |
| 2025-03-31 | 10-Q | – | -16.482.000 $ | -0,62 $ | 369.674.000 $ | 351.769.000 $ |
| 2024-12-31 | 10-K | – | -61.688.000 $ | -15,99 $ | 185.752.000 $ | -163.713.000 $ |
| 2024-09-30 | 10-Q | – | -25.441.000 $ | -5,67 $ | – | -148.549.000 $ |
| 2024-06-30 | 10-Q | – | -8.552.000 $ | -2.710,00 $ | – | -133.774.000 $ |
| 2024-03-31 | 10-Q | – | -11.847.000 $ | -3.840,00 $ | – | -126.083.000 $ |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 12.05.2026 | – | -0,60 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | – | -0,46 |
| Q2 2025 | 30.06.2025 | 11.08.2025 | – | -410,00 |
| Q1 2025 | 31.03.2025 | 12.05.2025 | – | -0,62 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | – | -5,67 |
| Q2 2024 | 30.06.2024 | 11.08.2025 | – | -2.710,00 |
| Q1 2024 | 31.03.2024 | 12.05.2025 | – | -3.840,00 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 12.05.2026 | 10-Q | 31.03.2026 | 42 Tage | SEC » |
| 02.03.2026 | 10-K | 31.12.2025 | 61 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 11.08.2025 | 10-Q | 30.06.2025 | 42 Tage | SEC » |
| 12.05.2025 | 10-Q | 31.03.2025 | 42 Tage | SEC » |
| 20.03.2025 | 10-K | 31.12.2024 | 79 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 07.02.2025 | Börsengang | $177,2 Mio · $18,00/Aktie | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 27.04.2026 | HV-Einladung | — | — | DEFA14A | SEC » |
| 27.04.2026 | HV-Einladung | 17.06.2026 Jahres-HV | 21.04.2026 | DEF 14A | SEC » |
| 29.04.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2025 | HV-Einladung | 12.06.2025 Jahres-HV | 15.04.2025 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 12.05.2026 | Sonstiges | 0,00 | 15 | Item 2.02 Ergebnisbericht ohne detaillierte Finanzinformationen im bereitgestellten Auszug vorhanden. | SEC |
| 02.03.2026 | Sonstiges | 0,00 | 5 | Filing enthält nur Boilerplate-Text; tatsächliche Geschäftsergebnisse befinden sich in nicht bereitgestelltem Exhibit 99.1. | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-30 | 9.681 | 42,97 | 415.993 |
| 2026-06-29 | 120.409 | 42,18 | 5.078.852 |
| 2026-06-25 | 1.101 | 41,09 | 45.240 |
| 2026-06-24 | 1.886 | 39,87 | 75.195 |
| 2026-06-23 | 90 | 38,83 | 3.495 |
| 2026-06-22 | 66 | 37,30 | 2.462 |
| 2026-06-15 | 353 | 35,92 | 12.680 |
| 2026-06-12 | 186 | 36,05 | 6.705 |
| 2026-06-10 | 24.749 | 33,69 | 833.794 |
| 2026-05-29 | 34.888 | 42,80 | 1.493.206 |
| 2026-05-27 | 709 | 42,88 | 30.402 |
| 2026-05-26 | 110 | 41,13 | 4.524 |
| 2026-05-19 | 4 | 39,24 | 157 |
| 2026-05-18 | 70 | 40,22 | 2.815 |
| 2026-05-13 | 174 | 40,94 | 7.124 |
| 2026-05-12 | 1 | 45,95 | 46 |
| 2026-05-08 | 3.243 | 43,31 | 140.454 |
| 2026-05-07 | 198 | 43,29 | 8.571 |
| 2026-05-04 | 1.980 | 39,15 | 77.517 |
| 2026-05-01 | 66 | 38,70 | 2.554 |
| 2026-04-29 | 615 | 39,59 | 24.348 |
| 2026-04-28 | 1.307 | 39,21 | 51.247 |
| 2026-04-27 | 30 | 38,11 | 1.143 |
| 2026-04-22 | 6 | 41,79 | 251 |
| 2026-04-20 | 460 | 43,54 | 20.028 |
| 2026-04-17 | 721 | 45,24 | 32.618 |
| 2026-04-16 | 6.569 | 45,09 | 296.196 |
| 2026-04-14 | 397 | 41,77 | 16.583 |
| 2026-04-13 | 2.168 | 37,89 | 82.146 |
| 2026-04-10 | 10.848 | 38,89 | 421.879 |
| 2026-04-07 | 11 | 37,38 | 411 |
| 2026-04-06 | 15.308 | 40,49 | 619.821 |
| 2026-04-02 | 800 | 41,30 | 33.040 |
| 2026-04-01 | 22.220 | 40,09 | 890.800 |
| 2026-03-31 | 1 | 36,66 | 37 |
| 2026-03-26 | 30 | 37,08 | 1.112 |
| 2026-03-24 | 3.213 | 36,43 | 117.050 |
| 2026-03-19 | 937 | 34,40 | 32.233 |
| 2026-03-16 | 3.940 | 37,32 | 147.041 |
| 2026-03-13 | 1 | 36,68 | 37 |
| 2026-03-11 | 104 | 38,08 | 3.960 |
| 2026-03-09 | 285 | 35,93 | 10.240 |
| 2026-03-05 | 1 | 34,57 | 35 |
| 2026-03-03 | 398 | 33,92 | 13.500 |
| 2026-02-17 | 461 | 37,52 | 17.297 |
| 2026-02-13 | 1.377 | 37,64 | 51.830 |
| 2026-02-11 | 20.054 | 38,02 | 762.453 |
| 2026-02-09 | 7.157 | 36,11 | 258.439 |
| 2026-02-05 | 205 | 41,32 | 8.471 |
| 2026-02-04 | 55 | 44,48 | 2.446 |
| 2026-02-02 | 295 | 42,26 | 12.467 |
| 2026-01-30 | 810 | 42,44 | 34.376 |